000950 重药控股
已收盘 09-14 15:00:00
资讯
新帖
简况
股市必读：重药控股新发布《北京市竞天公诚律师事务所关于重药控股股份有限公司2026年第四次临时股东会的律师见证法律意见书》
证券之星 · 09-14 02:24
股市必读：重药控股新发布《北京市竞天公诚律师事务所关于重药控股股份有限公司2026年第四次临时股东会的律师见证法律意见书》
重药控股（000950）披露2026年第四次临时股东会决议公告，9月10日股价下跌1.31%
证券之星 · 09-10
重药控股（000950）披露2026年第四次临时股东会决议公告，9月10日股价下跌1.31%
重药控股：公司高度重视医保基金与医药企业直接结算政策的落地推进
证券之星 · 09-10
重药控股：公司高度重视医保基金与医药企业直接结算政策的落地推进
通用技术重药控股与碧迪医疗正式开启战略合作
同花顺 · 09-08
通用技术重药控股与碧迪医疗正式开启战略合作
重药控股（000950）披露董事、副总经理离任公告，9月2日股价下跌1.09%
证券之星 · 09-02
重药控股（000950）披露董事、副总经理离任公告，9月2日股价下跌1.09%
重药控股：8月28日召开业绩说明会，投资者参与
证券之星 · 08-28
重药控股：8月28日召开业绩说明会，投资者参与
重药控股（000950）2026年中报简析：净利润同比下降9.85%
证券之星 · 08-27
重药控股（000950）2026年中报简析：净利润同比下降9.85%
重药控股（000950）披露2026年半年度报告，8月25日股价上涨3.14%
证券之星 · 08-25
重药控股（000950）披露2026年半年度报告，8月25日股价上涨3.14%
垫资供货讨债难！重药控股422起诉讼涉12.89亿元，百亿元应收压身，医院欠款顽疾能否化解
市场资讯 · 08-14
垫资供货讨债难！重药控股422起诉讼涉12.89亿元，百亿元应收压身，医院欠款顽疾能否化解
股市必读：重药控股新发布《关于新增累计诉讼、仲裁案件情况的公告》
证券之星 · 08-06
股市必读：重药控股新发布《关于新增累计诉讼、仲裁案件情况的公告》
重药控股（000950）披露新增累计诉讼、仲裁案件情况，8月4日股价上涨1.27%
证券之星 · 08-04
重药控股（000950）披露新增累计诉讼、仲裁案件情况，8月4日股价上涨1.27%
重药控股与翰森制药正式启动新丰翼项目战略合作
南方财经网 · 07-23
重药控股与翰森制药正式启动新丰翼项目战略合作
重药控股：主要从事医药流通、医药研发（MAH）、医疗器械生产并投资参与医药工业
证券之星 · 07-16
重药控股：主要从事医药流通、医药研发（MAH）、医疗器械生产并投资参与医药工业
股市必读：重药控股（000950）7月13日董秘有最新回复
证券之星 · 07-14
股市必读：重药控股（000950）7月13日董秘有最新回复
重药控股：以医药流通为核心业务
证券之星 · 07-13
重药控股：以医药流通为核心业务
重药控股完成1540.66万股回购股份注销手续
证券日报 · 07-12
重药控股完成1540.66万股回购股份注销手续
重药控股的合规与经营风险透视：军采违规频发与三百亿应收款压力
新浪证券 · 07-10
重药控股的合规与经营风险透视：军采违规频发与三百亿应收款压力
股市必读：重药控股（000950）7月2日董秘有最新回复
证券之星 · 07-03
股市必读：重药控股（000950）7月2日董秘有最新回复
重药控股（000950）披露回购股份进展及结果暨股份变动公告，7月1日股价上涨1.8%
证券之星 · 07-01
重药控股（000950）披露回购股份进展及结果暨股份变动公告，7月1日股价上涨1.8%
重药控股（000950）披露副总经理离任公告，6月24日股价下跌2.66%
证券之星 · 06-24
重药控股（000950）披露副总经理离任公告，6月24日股价下跌2.66%
公司概况
公司名称：
重药控股股份有限公司
所属行业：
批发业
上市日期：
1999-09-16
主营业务：
重药控股股份有限公司的主营业务是医药商业、仓储物流、医药工业和研发等业务。公司的主要产品是药品、医疗器械、中药饮片、健康品。
发行价格：
4.63
{"stockData":{"symbol":"000950","market":"SZ","secType":"STK","nameCN":"重药控股","latestPrice":5.25,"timestamp":1789369404000,"preClose":5.19,"halted":0,"volume":13822189,"delay":0,"changeRate":0.0116,"floatShares":1713000000,"shares":1713000000,"eps":0.2096,"marketStatus":"已收盘","change":0.06,"latestTime":"09-14 15:00:00","open":5.18,"high":5.26,"low":5.15,"amount":72162300,"amplitude":0.0212,"askPrice":5.26,"askSize":3096,"bidPrice":5.25,"bidSize":70,"shortable":0,"etf":0,"ttmEps":0.2096,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789435800000},"marketStatusCode":5,"adr":0,"adjPreClose":5.19,"symbolType":"stock","openAndCloseTimeList":[[1789349400000,1789356600000],[1789362000000,1789369200000]],"highLimit":5.71,"lowLimit":4.67,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1712778096,"isCdr":false,"pbRate":0.76,"roa":"--","peRate":25.04771,"roe":"2.18%","epsLYR":0.22,"committee":-0.48828,"marketValue":8992000000,"turnoverRate":0.0081,"status":0,"floatMarketCap":8992000000},"requestUrl":"/m/hq/s/000950/wiki","defaultTab":"wiki","newsList":[{"id":"2667680477","title":"股市必读：重药控股新发布《北京市竞天公诚律师事务所关于重药控股股份有限公司2026年第四次临时股东会的律师见证法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667680477","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667680477?lang=zh_cn&edition=full","pubTime":"2026-09-14 02:24","pubTimestamp":1789323853,"startTime":"0","endTime":"0","summary":"公司公告汇总：重药控股2026年第四次临时股东会于9月10日召开，审议通过关于变更注册资本、注册地址暨修订《公司章程》的议案，同意股份数占出席会议有效表决权股份总数的99.7247%。律师认为本次股东会相关事项符合法律法规及公司章程规定，决议合法有效。出席会议股东共307人，代表股份占公司有表决权股份总数的59.5375%；其中中小股东305人，代表股份占公司有表决权股份总数的4.2358%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400000950.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0071","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666591225","title":"重药控股（000950）披露2026年第四次临时股东会决议公告，9月10日股价下跌1.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666591225","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666591225?lang=zh_cn&edition=full","pubTime":"2026-09-10 22:29","pubTimestamp":1789050553,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘，重药控股报收于5.29元，较前一交易日下跌1.31%，最新总市值为90.61亿元。近日，重药控股发布2026年第四次临时股东会决议公告。其中，中小股东305人，代表股份占公司有表决权股份总数的4.2358%。议案获得总表决同意股数占比99.7247%，中小股东同意占比96.1308%。本次会议决议合法有效，无否决提案情形。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000042237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666561655","title":"重药控股：公司高度重视医保基金与医药企业直接结算政策的落地推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2666561655","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666561655?lang=zh_cn&edition=full","pubTime":"2026-09-10 08:51","pubTimestamp":1789001473,"startTime":"0","endTime":"0","summary":"公司是否已经观察到相关区域新增应收账款、DSO或逾期应收占比出现改善？如具体金额不便透露，请说明下目前状态与未来的主要扩围方向，感谢重药控股回复：尊敬的投资者您好，公司高度重视医保基金与医药企业直接结算政策的落地推进。公司下游客户以等级医院为主，应收账款坏账风险整体可控；公司通过强化应收考核、严控 “两金”规模、加强采购管理、完善客户资信管理、建立常态化及分层催收机制，加快款项回收。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000007153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665328417","title":"通用技术重药控股与碧迪医疗正式开启战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2665328417","media":"同花顺","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665328417?lang=zh_cn&edition=full","pubTime":"2026-09-08 15:36","pubTimestamp":1788852960,"startTime":"0","endTime":"0","summary":"9月7日，通用技术重药控股与碧迪医疗召开“碧迪滴D 联商共赢”业务沟通会，正式签署战略合作协议。重药控股高级副总裁、党委委员李少宏，高级副总裁张欣，碧迪医疗大中华区渠道卓越部副总裁 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/20260908/c679696373.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/20260908/c679696373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0250","BK0071","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664810215","title":"重药控股（000950）披露董事、副总经理离任公告，9月2日股价下跌1.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664810215","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664810215?lang=zh_cn&edition=full","pubTime":"2026-09-02 23:02","pubTimestamp":1788361341,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，重药控股报收于5.46元，较前一交易日下跌1.09%，最新总市值为93.52亿元。近日，重药控股股份有限公司发布关于董事、副总经理离任的公告。公告显示，公司于2026年9月1日收到董事、副总经理陈义海先生的辞职报告。陈义海先生原定任期至第九届董事会任期届满，其转任不影响公司正常运作。截至公告日，陈义海先生未持有公司股份，不存在应履行而未履行的承诺事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200043449.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662509983","title":"重药控股：8月28日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2662509983","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662509983?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:02","pubTimestamp":1787925762,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年8月28日重药控股发布公告称公司于2026年8月28日召开业绩说明会。重药控股2026年中报显示，上半年度公司主营收入401.32亿元，同比下降2.57%；归母净利润2.54亿元，同比下降9.85%；扣非净利润2.43亿元，同比下降12.37%；其中2026年第二季度，公司单季度主营收入196.99亿元，同比下降4.26%；单季度归母净利润8372.19万元，同比下降46.68%；单季度扣非净利润7636.14万元，同比下降50.72%；负债率75.45%，投资收益1.39亿元，财务费用3.23亿元，毛利率6.79%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800053418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","000950","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662740746","title":"重药控股（000950）2026年中报简析：净利润同比下降9.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662740746","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662740746?lang=zh_cn&edition=full","pubTime":"2026-08-27 06:23","pubTimestamp":1787783009,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期重药控股发布2026年中报。根据财报显示，重药控股净利润同比下降9.85%。截至本报告期末，公司营业总收入401.32亿元，同比下降2.57%，归母净利润2.54亿元，同比下降9.85%。按单季度数据看，第二季度营业总收入196.99亿元，同比下降4.26%，第二季度归母净利润8372.19万元，同比下降46.68%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700011576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662753655","title":"重药控股（000950）披露2026年半年度报告，8月25日股价上涨3.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662753655","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662753655?lang=zh_cn&edition=full","pubTime":"2026-08-25 22:41","pubTimestamp":1787668887,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘，重药控股报收于5.58元，较前一交易日上涨3.14%，最新总市值为95.57亿元。该股当日开盘5.4元，最高5.6元，最低5.37元，成交额达2.01亿元，换手率为2.13%。近日，重药控股披露《2026年半年度报告》。报告显示，报告期内公司实现营业收入401.32亿元，同比下降2.57%；归属于上市公司股东的净利润为2.54亿元，同比下降9.85%；扣除非经常性损益后的净利润为2.43亿元，同比下降12.37%。基本每股收益为0.15元，稀释每股收益为0.15元，分别同比下降6.25%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500051536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659192560","title":"垫资供货讨债难！重药控股422起诉讼涉12.89亿元，百亿元应收压身，医院欠款顽疾能否化解","url":"https://stock-news.laohu8.com/highlight/detail?id=2659192560","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659192560?lang=zh_cn&edition=full","pubTime":"2026-08-14 10:08","pubTimestamp":1786673280,"startTime":"0","endTime":"0","summary":"其中重药（辽宁）有限公司、辽宁卫生服务有限公司分别起诉北票市中心医院，两笔欠款合计超4100万元；重庆医药集团陕西有限公司起诉渭南市临渭区中医医院涉案金额2520.96万元，起诉渭南市第二医院涉案金额1091.59万元；陕西华氏医药有限公司起诉渭南市精神病医院，逾期货款1072.19万元，上述医院相关案件均已出具生效民事调解书。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-08-14/doc-ininfvzs4257205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0071","000950","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657213015","title":"股市必读：重药控股新发布《关于新增累计诉讼、仲裁案件情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657213015","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657213015?lang=zh_cn&edition=full","pubTime":"2026-08-06 01:23","pubTimestamp":1785950589,"startTime":"0","endTime":"0","summary":"交易信息汇总资金流向8月5日主力资金净流入802.52万元，占总成交额2.86%；游资资金净流入2125.81万元，占总成交额7.57%；散户资金净流出2928.33万元，占总成交额10.42%。公司公告汇总关于新增累计诉讼、仲裁案件情况的公告重药控股股份有限公司公告，公司及控股子公司连续十二个月内新增尚未披露的诉讼、仲裁案件涉案金额共计128,878.07万元，占公司最近一期经审计归属于母公司净资产的11.17%。部分案件已作出一审判决或达成调解，部分仍在审理中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600001423.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656355427","title":"重药控股（000950）披露新增累计诉讼、仲裁案件情况，8月4日股价上涨1.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656355427","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656355427?lang=zh_cn&edition=full","pubTime":"2026-08-04 22:11","pubTimestamp":1785852687,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘，重药控股报收于5.57元，较前一交易日上涨1.27%，最新总市值为95.4亿元。近日，重药控股股份有限公司发布《关于新增累计诉讼、仲裁案件情况的公告》。公告显示，公司及控股子公司连续十二个月内新增尚未披露的诉讼、仲裁案件涉案金额共计128,878.07万元，占公司最近一期经审计归属于母公司净资产的11.17%。无单项金额超过1,000万元且占净资产10%以上的重大诉讼、仲裁事项。部分案件已作出一审判决或达成调解，部分仍在审理中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400041237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653184027","title":"重药控股与翰森制药正式启动新丰翼项目战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2653184027","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653184027?lang=zh_cn&edition=full","pubTime":"2026-07-23 11:07","pubTimestamp":1784776020,"startTime":"0","endTime":"0","summary":"南方财经7月23日电，据重药控股消息，7月22日，重药控股与翰森制药集团有限公司召开新丰翼项目签约会。根据协议，本次项目合作将覆盖重庆、河南、陕西、贵州、四川、甘肃、天津、宁夏、湖北9个省市。双方将整合自身优质资源，在市场准入、新兴业务等重点合作领域持续深化协同，打造产销一体化创新合作体系。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607233818638391.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607233818638391.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["03692","BK0071","BK1583","000950","BK0250","BK1589","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651411685","title":"重药控股：主要从事医药流通、医药研发（MAH）、医疗器械生产并投资参与医药工业","url":"https://stock-news.laohu8.com/highlight/detail?id=2651411685","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651411685?lang=zh_cn&edition=full","pubTime":"2026-07-16 15:03","pubTimestamp":1784185395,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股(000950)07月16日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，实验猴子价格越来越贵，会不会影响公司对创新药的研发？影响公司发展？重药控股回复：公司处于医药流通行业，主要从事医药流通、医药研发（MAH）、医疗器械生产并投资参与医药工业，其中医药流通为核心业务；医药研发主要以药品上市许可持有人的方式开展，目前以高端仿制药和特色现代中药为主。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600019000.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK1583","159883","BK1574","BK1515","BK0071","BK1161","BK1100","09996","09939","BK0250","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651753146","title":"股市必读：重药控股（000950）7月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2651753146","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651753146?lang=zh_cn&edition=full","pubTime":"2026-07-14 02:19","pubTimestamp":1783966749,"startTime":"0","endTime":"0","summary":"截至2026年7月13日收盘，重药控股报收于5.29元，上涨2.12%，换手率2.6%，成交量44.48万手，成交额2.36亿元。董秘最新回复投资者： 尊敬的董秘。交易信息汇总资金流向7月13日主力资金净流出165.05万元，占总成交额0.0%；游资资金净流出20.87万元；散户资金净流入185.92万元，占总成交额0.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400001669.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000950","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651119431","title":"重药控股：以医药流通为核心业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2651119431","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651119431?lang=zh_cn&edition=full","pubTime":"2026-07-13 16:03","pubTimestamp":1783929797,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股(000950)07月13日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘。贵公司有什么科技业务没？也可以收购些半导体芯片行业的做下转型升级的。重药控股回复：公司处于医药流通行业，主要从事医药流通、医药研发（MAH）、医疗器械生产并投资参与医药工业，其中以医药流通为核心业务。感谢您的关注与建议！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300022098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK1515","000950","BK0071","BK1161","BK0250","BK1574","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650163244","title":"重药控股完成1540.66万股回购股份注销手续","url":"https://stock-news.laohu8.com/highlight/detail?id=2650163244","media":"证券日报 ","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650163244?lang=zh_cn&edition=full","pubTime":"2026-07-12 19:09","pubTimestamp":1783854540,"startTime":"0","endTime":"0","summary":"重药控股股份有限公司发布公告称，公司已完成1540.66万股回购股份注销手续。 本次注销股份占注销前总股本的0.8915%，注销完成后，公司总股本由17.28亿股缩减至17.13亿股。重药控股表示，本次股份注销不会对公司经营、财务及债务履约能力产生重大影响，公司控制权未发生变化，仍符合上市条件。后续公司将办理注册资本变更、章程修订及工商变更登记等相关手续。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-07-12/doc-inihpymv7813129.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-07-12/doc-inihpymv7813129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000950","BK0250","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650902665","title":"重药控股的合规与经营风险透视：军采违规频发与三百亿应收款压力","url":"https://stock-news.laohu8.com/highlight/detail?id=2650902665","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650902665?lang=zh_cn&edition=full","pubTime":"2026-07-10 14:17","pubTimestamp":1783664220,"startTime":"0","endTime":"0","summary":" 从区域龙头到央企子公司，重药控股在完成股权层面跨越的同时，其合规管理与经营质量正面临持续检验。近日，军队采购网公示信息显示，重药控股全资子公司重庆医药集团四川医药有限公司因“围标串标”被暂停全军采购资格。股权变更并未自动带来治理能力的同步提升，合规漏洞与经营压力仍是其面临的现实课题。 2024年以来，重药控股旗下至少7家子公司先后因军队采购违规被暂停资格，地域覆盖五个省级行政区。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-07-10/doc-inihhzsc8406567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000950","BK0071","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648687438","title":"股市必读：重药控股（000950）7月2日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2648687438","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648687438?lang=zh_cn&edition=full","pubTime":"2026-07-03 02:44","pubTimestamp":1783017852,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘，重药控股报收于5.17元，上涨1.37%，换手率1.82%，成交量31.43万手，成交额1.63亿元。公司公告汇总：重药控股股份回购已实施完毕，累计回购15,406,600股、支付8099.88万元，回购股份将全部注销以减少注册资本。本次回购已达到方案金额下限、未超上限，实施完毕；回购股份将全部注销，减少注册资本；相关主体在回购期间无买卖公司股票行为。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300002039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","000950","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648541676","title":"重药控股（000950）披露回购股份进展及结果暨股份变动公告，7月1日股价上涨1.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648541676","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648541676?lang=zh_cn&edition=full","pubTime":"2026-07-01 22:35","pubTimestamp":1782916514,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，重药控股报收于5.1元，较前一交易日上涨1.8%，最新总市值为88.14亿元。该股当日开盘4.99元，最高5.11元，最低4.93元，成交额达1.41亿元，换手率为1.62%。近日，重药控股披露《关于回购股份进展及结果暨股份变动的公告》。公告显示，公司于2025年7月审议通过回购股份方案，拟使用自有资金及专项贷款，以集中竞价方式回购公司股份，用于减少注册资本。回购股份将全部注销，减少注册资本。相关主体在回购期间无买卖公司股票行为。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100043574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645966819","title":"重药控股（000950）披露副总经理离任公告，6月24日股价下跌2.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645966819","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645966819?lang=zh_cn&edition=full","pubTime":"2026-06-24 22:22","pubTimestamp":1782310945,"startTime":"0","endTime":"0","summary":"截至2026年6月24日收盘，重药控股报收于5.13元，较前一交易日下跌2.66%，最新总市值为88.66亿元。近日，重药控股股份有限公司披露《关于副总经理离任的公告》。公告显示，公司于2026年6月24日收到副总经理杨清华女士提交的辞职申请，因其工作调整，申请辞去副总经理职务，转任公司调研经理。杨清华女士原定任期至第九届董事会届满，其职务变动不影响公司正常运营。截至公告日，其未持有公司股份，无应履行未履行承诺。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400043944.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","000950","BK0250"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789409492538,"stockEarnings":[{"period":"1week","weight":-0.0205},{"period":"1month","weight":-0.1653},{"period":"3month","weight":0.0077},{"period":"6month","weight":-0.0687},{"period":"1year","weight":0.0067},{"period":"ytd","weight":-0.0884}],"compareEarnings":[{"period":"1week","weight":-0.012},{"period":"1month","weight":-0.0107},{"period":"3month","weight":-0.0505},{"period":"6month","weight":-0.0437},{"period":"1year","weight":0.0038},{"period":"ytd","weight":-0.021}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"重药控股股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"48253人(较上一季度减少7.33%)","perCapita":"35495股","listingDate":"1999-09-16","address":"重庆市两江新区金石大道303号","registeredCapital":"171277万元","survey":" 重药控股股份有限公司的主营业务是医药商业、仓储物流、医药工业和研发等业务。公司的主要产品是药品、医疗器械、中药饮片、健康品。","listedPrice":4.63},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"重药控股(000950)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供重药控股(000950)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"重药控股,000950,重药控股股票,重药控股股票老虎,重药控股股票老虎国际,重药控股行情,重药控股股票行情,重药控股股价,重药控股股市,重药控股股票价格,重药控股股票交易,重药控股股票购买,重药控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"重药控股(000950)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供重药控股(000950)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}